Stock Fundamentals

Company Information

Company Name
DexCom Inc
Sector
Healthcare
Industry
Medical Devices
Exchange
NASDAQ
ISIN: US2521311074
CIK: 0001093557
CUSIP: 252131107
Currency: USD
Full Time Employees: 11,000
Phone: 858 200 0200
Fiscal Year End: December
IPO Date: Apr 14, 2005
Description:

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.

Address:

6340 Sequence Drive, San Diego, CA, United States, 92121

Directors & Officers

Name Title Year Born
Mr. Kevin Ronald Sayer Executive Chairman of the Board 1958
Mr. Jacob Steven Leach President, CEO & Director 1978
Mr. Jereme M. Sylvain CPA Executive VP, CFO & Chief Accounting Officer 1980
Mr. Michael Jon Brown J.D. Executive VP & Chief Legal Officer 1970
Ms. Sadie M. Stern Executive VP & Chief Human Resources Officer 1975
Mr. Jon Coleman Executive VP & Chief Commercial Officer 1964
Mr. Peter Simpson Executive VP & CTO NA
Mr. Sean Christensen Vice President of Finance and Investor Relations NA
Mr. Matthew Dolan Executive Vice President of Strategy & Corporate Development 1981
Mr. Donald M. Abbey Executive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs 1967

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 15, 2026 Michael Jon Brown N/A Sale 1.70K $63.04 $107.17K
Mar 30, 2026 Ro Khanna N/A Sale N/A $61.90 N/A
Mar 23, 2026 Ro Khanna N/A Sale N/A $65.94 N/A
Mar 16, 2026 Michael Jon Brown N/A Sale 1.70K $64.85 $110.25K
Feb 17, 2026 Ro Khanna N/A Purchase N/A $70.43 N/A
Feb 05, 2026 Ro Khanna N/A Sale N/A $69.89 N/A
Feb 04, 2026 Michael T. McCaul N/A Sale N/A $70.83 N/A
Jan 29, 2026 Ro Khanna N/A Purchase N/A $74.00 N/A
Jan 26, 2026 John Boozman N/A Purchase N/A $73.34 N/A
Nov 14, 2025 Richard Alexander Collins N/A Sale 2.91K $59.05 $171.60K
Nov 12, 2025 Bridgette P Heller N/A Sale 1.01K $58.07 $58.77K
Nov 10, 2025 Jacob Steven Leach N/A Purchase 18.20K $55.04 $1.00M
Nov 10, 2025 Richard Alexander Collins N/A Sale 3.95K $55.17 $217.81K
Oct 27, 2025 Michael T. McCaul N/A Sale N/A $70.63 N/A
Sep 29, 2025 Ro Khanna N/A Sale N/A $66.46 N/A
Sep 22, 2025 Michael T. McCaul N/A Purchase N/A $69.51 N/A
Sep 05, 2025 Kyle Malady N/A Sale 667.00 $80.86 $53.93K
Sep 04, 2025 Sadie Stern N/A Sale 1.47K $80.00 $117.28K
Aug 21, 2025 Michael T. McCaul N/A Sale N/A $80.62 N/A
Aug 15, 2025 Michael Jon Brown N/A Sale 500.00 $80.29 $40.15K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Vanguard Group Inc 49.07M Dec 31, 2025 12.72% $0.05 -0.77%
BlackRock Inc 38.96M Mar 31, 2026 10.10% $0.04 -2.22%
State Street Corp 17.93M Mar 31, 2026 4.65% $0.04 -0.88%
Baillie Gifford & Co Limited. 15.60M Mar 31, 2026 4.04% $1.00 0.30%
AllianceBernstein L.P. 12.92M Mar 31, 2026 3.35% $0.28 49.85%
Geode Capital Management, LLC 12.35M Mar 31, 2026 3.20% $0.05 12.18%
UBS Asset Mgmt Americas Inc 9.75M Mar 31, 2026 2.53% $0.13 21.84%
Wellington Management Company LLP 9.33M Mar 31, 2026 2.42% $0.11 203.43%
NORGES BANK 7.28M Dec 31, 2025 1.89% $0.05 40.25%
Amundi 6.33M Mar 31, 2026 1.64% $0.11 28.77%
JPMorgan Chase & Co 6.00M Mar 31, 2026 1.55% $0.02 -3.49%
Amvescap Plc. 5.59M Mar 31, 2026 1.45% $0.05 5.26%
Morgan Stanley - Brokerage Accounts 5.04M Mar 31, 2026 1.31% $0.02 -0.60%
UBS Group AG 4.35M Mar 31, 2026 1.13% $0.04 126.12%
Ameriprise Financial Inc 4.24M Mar 31, 2026 1.10% $0.06 99.26%
CIBC Bancorp USA Inc. 4.22M Mar 31, 2026 1.09% $0.36 6,060.00%
Northern Trust Corp 3.43M Mar 31, 2026 0.89% $0.03 1.44%
Deutsche Bank AG 3.39M Mar 31, 2026 0.88% $0.07 -21.63%
Charles Schwab Investment Management Inc 3.18M Mar 31, 2026 0.82% $0.03 3.12%
Atlantic Trust Group, LLC 3.13M Dec 31, 2025 0.81% $0.35 7.58%

Shares Statistics

Shares Outstanding: 385.87M
Shares Float: 384.00M
% Insiders: 26.80%
% Institutions: 10,272.50%
Short % Float: 5.24%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Vanguard Total Stock Mkt Idx Inv 12.26M 3.18% ▲ 0.24% Apr 30, 2026
2 Vanguard 500 Index Investor 9.98M 2.59% ▲ 1.83% Apr 30, 2026
3 Vanguard Mid Cap Index Institutional 8.33M 2.16% ▲ 0.23% Apr 30, 2026
4 Invesco QQQ Trust 8.24M 2.13% ▲ 0.74% Apr 30, 2026
5 Vanguard Health Care Inv 6.06M 1.57% ▲ 0.00% Mar 31, 2026
6 iShares Core S&P 500 ETF 4.98M 1.29% ▲ 0.29% Apr 30, 2026
7 Fidelity 500 Index 4.92M 1.27% ▼ 0.98% Mar 31, 2026
8 Vanguard Growth Index Investor 4.88M 1.26% ▲ 0.52% Apr 30, 2026
9 State Street® SPDR® S&P 500® ETF 4.58M 1.19% ▲ 0.33% Apr 30, 2026
10 UBS: Global Equity 4.17M 1.08% ▲ 0.00% Dec 31, 2025

Valuation Metrics

Enterprise Value: $27.86B
Trailing P/E: 31.52
Forward P/E: 29.24

Financial Highlights

Market Cap: $28.34B
EBITDA: $1.29B
P/E Ratio: $31.52
PEG Ratio: $1.40
Book Value: $7.66
Earnings/Share: $2.33
Profit Margin: 19.31%
Operating Margin: 21.42%
ROA (TTM): 9.65%
ROE (TTM): 35.62%
Revenue (TTM): $4.82B
Revenue/Share (TTM): $12.40
Earnings Growth (YOY): 92.20%
Revenue Growth (YOY): 15.00%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2025-12-31 1.88x 0.46x 0.57x 49.83x 1.08x
2024-12-31 1.47x 1.17x 0.68x 31.58x 2.61x
2023-12-31 2.84x 1.19x 0.67x 29.44x 2.68x
2022-12-31 1.99x 0.93x 0.60x 21.03x 3.52x
2021-12-31 5.11x 0.84x 0.59x 14.14x 4.56x
2020-12-31 5.58x 0.92x 0.57x 3.54x 4.47x
2019-12-31 5.47x 1.22x 0.63x 2.36x 5.03x
2018-12-31 7.64x 1.54x 0.65x -8.21x -13.68x
2017-12-31 5.36x 0.86x 0.54x -3.32x -18.32x
2016-12-31 2.73x 0.14x 0.30x -91.29x -0.79x
2015-12-31 3.46x 0.01x 0.24x -142.75x -0.05x
2014-12-31 3.59x 0.03x 0.24x -26.88x -0.35x
2013-12-31 2.90x 0.08x 0.31x -32.11x -0.31x
2012-12-31 3.98x 0.09x 0.27x -278.50x -0.14x
2011-12-31 7.08x 0.00x 0.13x -4,076.64x 0.00x
2010-12-31 4.36x 0.01x 0.21x -29.26x -0.01x
2009-12-31 1.96x -2.53x 1.39x -5.70x -1.08x
2008-12-31 2.14x -3.25x 1.87x -7.25x -1.27x
2007-12-31 7.97x 8.77x 0.91x N/A -1.44x
2006-12-31 10.97x 0.05x 0.12x N/A -0.06x
2005-12-31 7.21x 0.00x 0.13x N/A 0.00x
2004-12-31 17.39x 0.00x 2.68x N/A 0.00x
2003-12-31 20.47x 0.00x 2.57x N/A 0.00x
2002-12-31 N/A N/A N/A N/A 0.00x
2001-12-31 N/A 0.00x 0.00x N/A 0.00x
2000-12-31 N/A 0.00x 0.00x N/A 0.00x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about DXCM.US!